Cook Children's Health Care System
14
6
7
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Robot-assisted Training in Children With CP
Role: lead
Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study
Role: lead
Effect of Ipratropium Bromide on EILO
Role: lead
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
Role: collaborator
Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib
Role: lead
Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD
Role: lead
The Pediatric Anesthesia Quality Improvement Project
Role: collaborator
Endomicroscopic Evaluation of Food-induced Gastrointestinal Mucosal Alteration
Role: lead
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
Role: lead
Massage Therapy After Thoracic or Lumbar Surgery
Role: lead
Multicenter Comparison of Interictal HFO as a Predictor of Seizure Freedom
Role: collaborator
GABA Biomarkers in Dravet Syndrome
Role: lead
Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
Role: lead
Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in Children
Role: lead
All 14 trials loaded